|
1
|
Sjoquist KM and Zalcberg JR: Gastric
cancer: Past progress and present challenges. Gastric Cancer.
18:205–209. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin MT, Lin BR, Chang CC, Chu CY, Su HJ,
Chen ST, Jeng YM and Kuo ML: IL-6 induces AGS gastric cancer cell
invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
Int J Cancer. 120:2600–2608. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dassen AE, Lemmens VE, van de Poll-Franse
LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ, Wurff Vd AA, Bosscha K
and Coebergh JW: Trends in incidence, treatment and survival of
gastric adenocarcinoma between 1990 and 2007: A population-based
study in The Netherlands. Eur J Cancer. 46:1101–1110. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Szász AM, Lánczky A, Nagy Á, Förster S,
Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B:
Cross-validation of survival associated biomarkers in gastric
cancer using transcriptomic data of 1,065 patients. Oncotarget.
7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamamoto T, Gotoh M, Sasaki H, Terada M,
Kitajima M and Hirohashi S: Molecular cloning and initial
characterization of a novel fibrinogen-related gene, HFREP-1.
Biochem Biophys Res Commun. 193:681–687. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Demchev V, Malana G, Vangala D, Stoll J,
Desai A, Kang HW, Li Y, Nayeb-Hashemi H, Niepel M, Cohen DE and
Ukomadu C: Targeted deletion of fibrinogen like protein 1 reveals a
novel role in energy substrate utilization. PLoS One. 8:e580842013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hara H, Yoshimura H, Uchida S, Toyoda Y,
Aoki M, Sakai Y, Morimoto S and Shiokawa K: Molecular cloning and
functional expression analysis of a cDNA for human hepassocin, a
liver-specific protein with hepatocyte mitogenic activity. Biochim
Biophys Acta. 1520:45–53. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li CY, Cao CZ, Xu WX, Cao MM, Yang F, Dong
L, Yu M, Zhan YQ, Gao YB, Li W, et al: Recombinant human hepassocin
stimulates proliferation of hepatocytes in vivo and improves
survival in rats with fulminant hepatic failure. Gut. 59:817–826.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Z and Ukomadu C: Fibrinogen-like
protein 1, a hepatocyte derived protein is an acute phase reactant.
Biochem Biophys Res Commun. 365:729–734. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nayeb-Hashemi H, Desai A, Demchev V,
Bronson RT, Hornick JL, Cohen DE and Ukomadu C: Targeted disruption
of fibrinogen like protein-1 accelerates hepatocellular carcinoma
development. Biochem Biophys Res Commun. 465:167–173. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan J, Yu Y, Wang N, Chang Y, Ying H, Liu
W, He J, Li S, Jiang W, Li Y, et al: LFIRE-1/HFREP-1, a
liver-specific gene, is frequently downregulated and has growth
suppressor activity in hepatocellular carcinoma. Oncogene.
23:1939–1949. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Grunert S, Jechlinger M and Beug H:
Diverse cellular and molecular mechanisms contribute to epithelial
plasticity and metastasis. Nat Rev Mol Cell Biol. 4:657–665. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Giannelli G, Koudelkova P, Dituri F and
Mikulits W: Role of epithelial to mesenchymal transition in
hepatocellular carcinoma. J Hepatol. 65:798–808. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Prasad CP, Rath G, Mathur S, Bhatnagar D,
Parshad R and Ralhan R: Expression analysis of E-cadherin, Slug and
GSK3beta in invasive ductal carcinoma of breast. BMC Cancer.
9:3252009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang W, Altholland A, Margulis A, Shamis
Y, Fusenig NE, Rodeck U and Garlick JA: E-cadherin loss promotes
the initiation of squamous cell carcinoma invasion through
modulation of integrin-mediated adhesion. J Cell Sci. 119:283–291.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakajima S, Doi R, Toyoda E, Tsuji S, Wada
M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, et al: N-cadherin
expression and epithelial-mesenchymal transition in pancreatic
carcinoma. Clin Cancer Res. 10:4125–4133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou J, Tao D, Xu Q, Gao Z and Tang D:
Expression of E-cadherin and vimentin in oral squamous cell
carcinoma. Int J Clin Exp Pathol. 8:3150–3154. 2015.PubMed/NCBI
|
|
21
|
Xie X, Zheng X, Wang J and Chen L:
Clinical significance of Twist, E-cadherin, and N-cadherin protein
expression in endometrioid adenocarcinoma. J Cancer Res Ther.
13:817–822. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Avila D: N-cadherin and vimentin
expression in small rounded-shaped cells of non-functioning human
pituitary adenomas. Int J Clin Exp. 9:7854–7866. 2016.
|
|
23
|
Satelli A and Li S: Vimentin in cancer and
its potential as a molecular target for cancer therapy. Cell Mol
Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
|
